Point-of-Care Molecular Diagnostics Market presents an in-depth assessment of the market dynamics, opportunities, future road-map, and competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Point-of-Care Molecular Diagnostics market. The report includes historical data from 2016 to 2021 and forecasts until 2027. The report covers the post-COVID-19 (Corona Virus) impact on various regions and major countries and on the future development of the industry is pointed out.
Top Companies in the Global Point-of-Care Molecular Diagnostics Market: Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Danaher Corporation, BioMerieux, Agilent Technologies, OraSure Technologies Inc., Thermo Fisher Scientific (Qiagen NV), etc.
Get Sample copy of this Report:
Point-of-Care (POC) Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help prescribe treatment in the first instance without having to wait for final results. In past decades, the prevalence of infectious diseases and chronic illnesses like cancer have increased.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Point-of-Care Molecular Diagnostics Market these regions, from 2021 to 2025 (forecast), covering North America, Europe, China, Japan, Southeast Asia, India, North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia–Pacific (China, Japan, Korea, India and Southeast).
Key Market Trends:
Application in Oncology is Expected to Register a High CAGR
Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040. This is an increase of 61.7% from 17 million new cancer cases worldwide in 2018.
Many current point-of-care (POC) diagnostics utilize lateral flow immunoassay based technologies. Lateral flow immunoassays are devices that incorporate antibodies to detect the presence of an analyte like cancer biomarkers. In principle, a lateral flow test is a device that will provide a qualitative answer to the presence of a biomarker in a short period of time. Hence, the demand for these quick detection tests is expected to increase as the incidence of cancer increases.
Browse for complete Report:
The conclusion summarized in the report study is helpful for:
-Knowing the current global scenario of the Point-of-Care Molecular Diagnostics market and the market shares of the present global leaders.
-The report is helpful in getting insights about the business strategies adopted by all the leading players along with the development done by these players to strengthen their global position.
-The report also suggests business strategies for the existing players and new players in the market space to enter and make a significant impact on the market shares scenario of the market.
-The report is anticipated to assist the decision-makers in the industry by providing necessary key insights of the market.
-Further, a detailed analysis of the technology ecosystem of the Point-of-Care Molecular Diagnostics is provided in the report; which is expected to help the key decision-makers of the market.
The report covers market dynamics affecting the market during the forecast period. Moreover, the report analyses the competitive situation, geographic trends, and opportunities within the markets with regard to all geographic regions. The report conjointly includes the detailed company profiles of the key players in the market beside their market strategies. The report additionally provides pest analysis of all five regions along with the SWOT analysis for all company profiled in the report.
We Also Offer Customization on report based on specific client Requirement:
– Free country Level analysis for any 5 countries of your choice.
– Free Competitive analysis of any 5 key market players.
– Free 40 analyst hours to cover any other data point.
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
firstname.lastname@example.org | email@example.com